ArticleBritish journal of clinical pharmacology2023

Safety of off-label dose reduction of non-vitamin K antagonist oral anticoagulants in patients with atrial fibrillation.

Carline J van den Dries et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.